Diuretic formulations

Details Diuretic formulations Diuretic formulations

A - Human Necessities

61

K

167/193, 167/224

A61K 31/57 (2006.01) A61K 31/495 (2006.01) A61K 31/585 (2006.01) C07D 241/26 (2006.01) C07D 333/22 (2006.01)

Patent

CA 1075155

ABSTRACT OF THE DISCLOSURE The potassium conserving diuretics, N-amidino- 3,5-diamino-6-chloropyrazinecarboxamide and its hydro- chloride, 2-oxygenated-6,7-methylene-2?-spirozanes; 17-a- pregnase-21-carboxylic acids and spironolactone are orally co-administered with 4-substituted carbonyl-2,3-dichloro- phenoxyacetic acid diuretics wherein the substituents are furyl, thienyl, or loweralkylthienyl as mixtures or, in the instance of N-amidino-3,5-diamino-6-chloropyrazinamide, as salts to avoid hypokalemia in patients.

244829

Affiliated with

Also associated with

Rating

Diuretic formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diuretic formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diuretic formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-638083